Emeka Spółka z Ograniczoną Odpowiedzialnością (KRS 0000960122, NIP 5892071809) is a Polish company, headquartered in Gdańsk, Pomorskie voivodeship. Emeka operates in: Wholesale of textiles (PKD 46.41.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since March 22, 2022. Emeka's most recently reported net revenue was 25.9 K PLN for 2024.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Emeka
Identity
- Name
- Emeka Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- March 22, 2022
- Registry status as of
- January 1, 2026
- Latest entry
- December 31, 2025
- Founding act
- 28.02.2022 R.
Articles of association history (2)
- February 28, 2022: 28.02.2022 R.
- December 5, 2025: 05.12.2025 R. REP. A NUMER 3343/2025 KANCELARIA NOTARIALNA MAŁGORZATA WOLECKA - NOTARIUSZ, ZMIANA §3 UMOWY SPÓŁKI
Activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. JANA HEWELIUSZA, 11, 811, 80-890, GDAŃSK, POLSKA
- Voivodeship
- POMORSKIE
- District
- GDAŃSK
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-15470-10841-ASVUT-24
- Coordinates
- 54.3598, 18.6360approx.
Risk and payment profile - Emeka
Credibility rating
21.8 / 100
Poor credibility
Insolvency risk
Moderate
Significant formal threat
Closure risk
36
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/4 yrs
Board changes
0
0/4 yrs
PKD changes
1
1/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Credibility history
Payment reliability score from 2022–2024
Current: E (22/100)
Trend: deteriorating (-9.4 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2022–2024
Current: 511.28 PLN
Safe: 86.92 PLN
Operational status - Emeka
Founded
March 22, 2022
4 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GDAŃSK
POMORSKIE
Primary PKD
46.41.Z
Wholesale of textiles
Share capital
5.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
3 years
2022–2024 · profitable: 0/3
Registry entries
11
latest: December 31, 2025
Risk signals
Revenue
25.9 K PLN
2024
Net profit
-3.9 K PLN
2024
Assets
17.1 K PLN
2024
Equity
1.1 K PLN
2024
EBITDA
N/A
2024
no depreciation data
Valuation
8.5 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Emeka.
No ratings
Related articles
Explainer
Eurocash in 2026: Poland's FMCG-wholesale leader and the Delikatesy Centrum network – an mWIG40 issuer near Poznań controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral and listed on the WSE since 2005, the company is an mWIG40 constituent. Its 2025 financial statements show revenue of around PLN 30.0bn and a net loss of about PLN 336m. A six-member management board and a five-member supervisory board chaired by the founder.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by a gradual normalisation. Listed on the WSE since 2013, with a three-member management board and a five-member supervisory board.
